Reduction in curie score in neuroblastoma patients treated with naxitamab.

被引：0
|
作者：
Mora, Jaume
Chan, Godfrey Chi-Fung
Morgenstern, Daniel A.
Amoroso, Loredana
Nysom, Karsten
Faber, Joerg
Wingerter, Arthur
Bear, Melissa
Rubio-San-Simon, Alba
Kushner, Brian H.
Tornoe, Karen
Christensen, Rene DePont
机构：
[1] Hosp San Juan Dios, Pediat Canc Ctr Barcelona, Barcelona, Spain
[2] Univ Hong Kong, Hong Kong Childrens Hosp, Hong Kong, Peoples R China
[3] Univ Toronto, Hosp Sick Children, Toronto, ON, Canada
[4] IRCCS Ist Giannina Gaslini, Genoa, Italy
[5] Univ Hosp Rigshosp, Dept Pediat & Adolescent Med, Copenhagen, Denmark
[6] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Pediat & Adolescent Med, Mainz, Germany
[7] Indiana Univ Hlth, Riley Hosp Children, Indianapolis, IN USA
[8] Hosp Infantil Univ Nino Jesus, Madrid, Spain
[9] Mem Sloan Kettering Canc Ctr, New York, NY USA
[10] YmAbs Therapeut Inc, Horsholm, Denmark
[11] YmAbs AS, Horsholm, Denmark
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10042
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Institut Curie guidelines on breast target volume delineation for patients treated in lateral position
    Msika, R.
    Fourquet, A.
    Laki, F.
    Porte, B.
    Servois, V
    Kirova, Y.
    CANCER RADIOTHERAPIE, 2020, 24 (08): : 795 - 798
  • [32] Institut Curie guidelines on breast target volume delineation for patients treated in lateral position
    Msika, Rebecca
    Robilliard, Magalie
    Fourquet, Alain
    Porte, Baptiste
    Kirova, Youlia
    CANCER RESEARCH, 2020, 80 (04)
  • [33] "THE SENSE AND SENSIBILITY OF PHILADELPHIA SCORE" IN STAGE 4S NEUROBLASTOMA PATIENTS.
    Kraal, K.
    Nagtegaal, M.
    Van Noesel, M.
    Caron, H.
    Tytgat, G.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 120 - 120
  • [34] Outpatient administration of naxitamab in combination with granulocyte-macrophage colony-stimulating factor in patients with refractory and/or relapsed high-risk neuroblastoma: Management of adverse events
    Mora, Jaume
    Chan, Godfrey C.
    Morgenstern, Daniel A.
    Nysom, Karsten
    Bear, Melissa K.
    Tornoe, Karen
    Kushner, Brian H.
    CANCER REPORTS, 2023, 6 (01)
  • [35] Fertility preservation in young breast cancer patients: Real life data on 1390 patients treated in the Institut Curie
    Hamy-Petit, A-S
    Toussaint, A.
    Sautter, C.
    Coussy, F.
    Donnadieu, A.
    Rouzier, R.
    Saule, C.
    Frank, S.
    Bensen, A.
    Grynberg, M.
    Scarabin-Carre, V.
    Santulli, P.
    Balezeau, T.
    Guerin, J.
    Reyrat, E.
    Jamain, C.
    Hours, A.
    Lecourt, A.
    Reyal, F.
    CANCER RESEARCH, 2019, 79 (04)
  • [36] PILE: a candidate prognostic score in cancer patients treated with immunotherapy
    Guven, D. C.
    Yildirim, H. C.
    Bilgin, E.
    Aktepe, O. H.
    Taban, H.
    Sahin, T. K.
    Cakir, I. Y.
    Akin, S.
    Dizdar, O.
    Aksoy, S.
    Yalcin, S.
    Erman, M.
    Kilickap, S.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (08): : 1630 - 1636
  • [37] FRAX score: fracture risk assessment in treated HIV patients
    Falutz, J.
    Rosenthall, L.
    ANTIVIRAL THERAPY, 2009, 14 (07) : A31 - A31
  • [38] Accuracy of the GAP Score in IPF Patients Treated with Antifibrotic Therapy
    Pastre, J.
    Valery, S.
    Brown, A. W.
    Shlobin, O. A.
    Ahmad, K.
    Ahmad, K.
    Khangoora, V.
    Aryal, S.
    King, C.
    Nathan, S. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [39] PILE: a candidate prognostic score in cancer patients treated with immunotherapy
    D. C. Guven
    H. C. Yildirim
    E. Bilgin
    O. H. Aktepe
    H. Taban
    T. K. Sahin
    I. Y. Cakir
    S. Akin
    O. Dizdar
    S. Aksoy
    S. Yalcin
    M. Erman
    S. Kilickap
    Clinical and Translational Oncology, 2021, 23 : 1630 - 1636
  • [40] PROGNOSTIC FACTORS OF ENDOMETRIAL CANCER - ANALYSIS OF A SERIES OF 206 PATIENTS TREATED AT THE INSTITUT-CURIE
    CHEN, Q
    DELAROCHEFORDIERE, A
    MOURETFOURME, E
    DURAND, JC
    CLOUGH, K
    ASSELAIN, B
    LABIB, A
    FENTON, J
    BULLETIN DU CANCER, 1995, 82 (09) : 717 - 723
12345